Oral PrimeC for ALS significantly reduced toxic TDP-43 protein levels in a Phase 2b trial. PrimeC also slowed functional decline and extended survival by about 15 months. The treatment was well ...

Digging deep into the molecular mechanisms behind ALS, researchers at the Les Turner ALS Center at Northwestern Medicine have ...

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...

Sarper and Jenny got to know each other on the current season of 'The Last Resort.' ...

A new pancreatic cancer drug doubles survival times. And a new treatment for a rare form of ALS slows and improves some patients' symptoms.

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease. Individuals affected by ALS include those living with ALS, their caregivers, presymptomatic ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved RELYVRIO™ ...

The MarketWatch News Department was not involved in the creation of this content. Treatments Are Within Reach: Reintroduced ACT for ALS Bill Would Help Get Them to People Living with ALS Faster ...

The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.

Individuals diagnosed with ALS are immediately eligible for Medicare upon receiving Social Security Disability Insurance (SSDI), regardless of their age. Original Medicare (parts A and B) generally ...